Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Inge Henter

Showing results (101-110 of 201) with videos related to

Pageof 21
Sort By:
British Journal of Haematology|November 17, 2025
Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosisKatarina Zivkovic, Elisabet Bergsten, Maurizio Aricó, et al.
Methodsx|August 11, 2020
Comparison of three different ELISAs for the detection of recombinant, native and plasma IL-17AMohamad Bachar Ismail, Selma Olsson Åkefeldt, Magda Lourda, et al.
Human Genetics|December 17, 2002
Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosisKim Göransdotter Ericson, Bengt Fadeel, Mats Andersson, et al.
The Journal of Allergy and Clinical Immunology|June 3, 2014
Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficienciesStephan Borte, Marie Meeths, Ines Liebscher, et al.
Stem Cells and Development|June 29, 2012
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cellsDimitrios Mougiakakos, Maciej Machaczka, Regina Jitschin, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2020
Foxp3<sup>+</sup> Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacityJenée Mitchell, Jason Kelly, Egle Kvedaraite, et al.
British Journal of Haematology|March 30, 2007
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropeniaJenny Karlsson, Göran Carlsson, Kim Göransdotter Ramme, et al.
Frontiers in Immunology|March 17, 2022
Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine PatternsXiao-Jun Xu, Ze-Bin Luo, Hua Song, et al.
British Journal of Haematology|July 9, 2020
High prevalence of peripheral lymphopenia in Langerhans cell histiocytosisMagda Lourda, Sofie Widesköld, Egle Kvedaraite, et al.
British Journal of Haematology|November 18, 2020
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cellsAvinash Khandagale, Teresa Holmlund, Miriam Entesarian, et al.
Pageof 21

Showing results (101-110 of 201) with videos related to

Sort By:
Pageof 21
British Journal of Haematology|November 17, 2025
Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosisKatarina Zivkovic, Elisabet Bergsten, Maurizio Aricó, et al.
Methodsx|August 11, 2020
Comparison of three different ELISAs for the detection of recombinant, native and plasma IL-17AMohamad Bachar Ismail, Selma Olsson Åkefeldt, Magda Lourda, et al.
Human Genetics|December 17, 2002
Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosisKim Göransdotter Ericson, Bengt Fadeel, Mats Andersson, et al.
The Journal of Allergy and Clinical Immunology|June 3, 2014
Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficienciesStephan Borte, Marie Meeths, Ines Liebscher, et al.
Stem Cells and Development|June 29, 2012
Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cellsDimitrios Mougiakakos, Maciej Machaczka, Regina Jitschin, et al.
Clinical Immunology (Orlando, Fla.)|April 14, 2020
Foxp3<sup>+</sup> Tregs from Langerhans cell histiocytosis lesions co-express CD56 and have a definitively regulatory capacityJenée Mitchell, Jason Kelly, Egle Kvedaraite, et al.
British Journal of Haematology|March 30, 2007
Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropeniaJenny Karlsson, Göran Carlsson, Kim Göransdotter Ramme, et al.
Frontiers in Immunology|March 17, 2022
Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine PatternsXiao-Jun Xu, Ze-Bin Luo, Hua Song, et al.
British Journal of Haematology|July 9, 2020
High prevalence of peripheral lymphopenia in Langerhans cell histiocytosisMagda Lourda, Sofie Widesköld, Egle Kvedaraite, et al.
British Journal of Haematology|November 18, 2020
Severe congenital neutropenia-associated JAGN1 mutations unleash a calpain-dependent cell death programme in myeloid cellsAvinash Khandagale, Teresa Holmlund, Miriam Entesarian, et al.
Pageof 21